Valneva Comments on COV-Boost Clinical Trial Data

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

United Kingdom ,Japan ,Japanese ,Astrazeneca Vaxzevria ,Juan Carlos Jaramillo ,Joshua Drumm ,Global Communications ,European Medicines Agency ,European Commission ,University Hospital Southampton ,United Kingdom Joint Committee On Vaccination ,Regulatory Agency ,Dynavax Technologies Corporation Nasdaq ,Saint Herblain ,Euronext Paris ,Joint Committee ,United Kingdom Medicines ,Carlos Jaramillo ,Chief Medical Officer ,Professor Faust ,Dynavax Technologies Corporation ,Media Contacts ,European Investor Relations ,Global Investor Relations ,Coronavirus Pandemic ,Technology ,Health ,Business ,Clinical Trials ,Europe ,Valneva Se ,Globe Newswire ,Coronavirus Vaccine ,Immunizations ,